Iontophoretic delivery of cytotoxic agents for the treatment of solid tumors Public Deposited

Downloadable Content

Download PDF
Last Modified
  • March 19, 2019
  • Byrne, James
    • Affiliation: Eshelman School of Pharmacy, Division of Pharmacoengineering and Molecular Pharmaceutics
  • Parenteral and oral routes have been the traditional methods of administering cytotoxic agents to cancer patients. Unfortunately, the maximum potential effect of these cytotoxic agents has been limited due to systemic toxicity and poor tumor perfusion. In an attempt to improve the efficacy of cytotoxic agents while mitigating their side effects, we have developed modalities for the localized iontophoretic delivery of cytotoxic agents. These pressurized, reservoir-based iontophoretic devices were designed to be implanted proximal to the tumor with external control of power and drug flow. Three distinct orthotopic mouse models of cancer and a canine model were evaluated for device efficacy and toxicity. In the mouse models, device delivery of cytotoxic agents resulted in enhanced drug accumulation in the tumor and tumor shrinkage. In dogs, device delivery resulted in large local drug concentrations and low systemic drug exposure. These devices have potential paradigm shifting implications for the treatment of pancreatic, breast, and other solid tumors.
Date of publication
Resource type
Rights statement
  • In Copyright
  • Tepper, Joel
  • Huang, Leaf
  • DeSimone, Joseph M.
  • Juliano, Rudolph
  • Yeh, Jen Jen
  • Doctor of Philosophy
Degree granting institution
  • University of North Carolina at Chapel Hill Graduate School
Graduation year
  • 2014
Place of publication
  • Chapel Hill, NC
  • This item is restricted from public view for 2 years after publication.

This work has no parents.